This association is partly due to its ability to alter glucose transporter translocation to the plasma membrane, thereby reducing systemic glucose uptake, and partly due to its ability to inhibit pro-insulin receptor cleavage, causing insulin resistance [71]. The gene discussed is INSR; the disease is Insulin resistance.